healthNewsغير مصنف

Lundbeck says Alzheimer’s drug fails in late-stage study

(Reuters) – Danish drugmaker H Lundbeck A/S’s highly anticipated experimental Alzheimer’s drug failed in a late-stage study, underscoring the challenges faced by drugmakers to tackle the debilitating memory-robbing disease.

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى